. Author manuscript; available in PMC: 2014 Dec 1.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Oct 14;22(12):2364–2373. doi: 10.1158/1055-9965.EPI-13-0237

Table 3. Over-expression of plasma miRNAs and HCC prediction in the 49 HCC case-control pairs of the validation set.

miRNAs over-expression^*	HCC, N (%)	Controls, N (%)	OR (95%CI)^**	p
miR-30c
No	42 (86)	36 (73)	1.00 (ref)
Yes	7 (14)	13 (27)	0.23 (0.04-1.43)	0.116
miR-150
No	37 (76)	36 (73)	1.00 (ref)
Yes	12 (24)	13 (27)	0.72 (0.13-4.05)	0.712
miR-483-5p
No	14 (29)	37 (76)	1.00 (ref)
Yes	35 (71)	12 (24)	9.66 (2.64-35.26)	0.0006

75^th percentile in controls is used as the cutoff point for miRNA over-expression

^**

Adjusted for age, gender, ethnicity and viral status (HBV and HCV)